Erbitux meets gold standard in rectal cancer | InPharm
Links shared publicly online about this topic.
- 237total visits
Erbitux meets gold standard in rectal cancer | InPharm
Rectal cancer trials of Merck Serono’s Erbitux have shown improved overall survival, a gold standard measure in oncology trials
View full resource at inpharm.com
Tags: Rectum, Cancer, Rectal Cancer, Erbitux, Merck & Co., Oncology
Most Recently Shared on June 7, 2011 at 8:09 am By:
Erbitux meets gold standard in rectal cancer http://goo.gl/fb/QrKXk
Advertisement
